Evidence map›Paper›PMID 38273253›Full record

ReviewThe journal of headache and pain2024

Migraine - a borderland disease to epilepsy: near it but not of it.

Jakob Paungarttner, Martina Quartana, Lucrezia Patti, Barbora Sklenárová, Fatemeh Farham, Inés Hernando Jiménez, M Gokcen Soylu, Irina Maria Vlad, Semih Tasdelen, Teresa Mateu and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in The journal of headache and pain, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. What does a migraine aura look like?-A systematic review.The journal of headache and pain · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Migraine and cognitive dysfunction: a narrative review.The journal of headache and pain · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 8 countries.

Jakob PaungarttnerHeadache Medical Center Linz, Linz, Austria.
Martina QuartanaDepartment of Sciences for Health Promotion and Mother-and Childcare "G. D'Alessandro", University of Palermo, Palermo, Italy.
Lucrezia PattiDepartment of Sciences for Health Promotion and Mother-and Childcare "G. D'Alessandro", University of Palermo, Palermo, Italy.
Barbora SklenárováSt. Anne's University Hospital and Masaryk University, Brno, Czech Republic.
Fatemeh FarhamHeadache Department, Iranian Center of Neurological Researchers, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Inés Hernando JiménezDepartment of Neurology, Severo Ochoa University Hospital, Madrid, Spain.
M Gokcen SoyluDepartment of Neurology, Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, Istanbul, Turkey.
Irina Maria VladDepartment of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Semih TasdelenDepartment of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Teresa MateuDepartment of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain.
Oreste MarsicoDepartment of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Federica ReinaNeuroTeam Life&Science, Spin-off University of Palermo, Palermo, Italy.
Viktoria TischlerHeadache Medical Center Linz, Linz, Austria.
Christian LamplHeadache Medical Center Linz, Linz, Austria. christian.lampl@bblinz.at.
European Headache Federation School of Advanced Studies (EHF – SAS)
University of Palermo · ITBakırköy Psychiatric Hospital · TRConvent Hospital of the Brothers of Saint John of God · ATHospital Universitario Severo Ochoa · ESIstanbul University · TRLinz Center of Mechatronics (Austria) · ATMasaryk University · CZMetropolitan Hospital · GRResearch Institute for Analytical Instrumentation · ROTehran University of Medical Sciences · IRVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMigraine and epilepsy are two paroxysmal chronic neurological disorders affecting a high number of individuals and being responsible for a high individual and socioeconomic burden. The link between these disorders has been of interest for decades and innovations concerning diagnosing and treatment enable new insights into their relationship.

findingsAlthough appearing to be distinct at first glance, both diseases exhibit a noteworthy comorbidity, shared pathophysiological pathways, and significant overlaps in characteristics like clinical manifestation or prophylactic treatment. This review aims to explore the intricate relationship between these two conditions, shedding light on shared pathophysiological foundations, genetic interdependencies, common and distinct clinical features, clinically overlapping syndromes, and therapeutic similarities. There are several shared pathophysiological mechanisms, like CSD, the likely underlying cause of migraine aura, or neurotransmitters, mainly Glutamate and GABA, which represent important roles in triggering migraine attacks and seizures. The genetic interrelations between the two disorders can be observed by taking a closer look at the group of familial hemiplegic migraines, which are caused by mutations in genes like CACNA1A, ATP1A2, or SCN1A. The intricate relationship is further underlined by the high number of shared clinical features, which can be observed over the entire course of migraine attacks and epileptic seizures. While the variety of the clinical manifestation of an epileptic seizure is naturally higher than that of a migraine attack, a distinction can indeed be difficult in some cases, e.g. in occipital lobe epilepsy. Moreover, triggering factors like sleep deprivation or alcohol consumption play an important role in both diseases. In the period after the seizure or migraine attack, symptoms like speech difficulties, tiredness, and yawning occur. While the actual attack of the disease usually lasts for a limited time, research indicates that individuals suffering from migraine and/or epilepsy are highly affected in their daily life, especially regarding cognitive and social aspects, a burden that is even worsened using antiseizure medication. This medication allows us to reveal further connections, as certain antiepileptics are proven to have beneficial effects on the frequency and severity of migraine and have been used as a preventive drug for both diseases over many years.

conclusionMigraine and epilepsy show a high number of similarities in their mechanisms and clinical presentation. A deeper understanding of the intricate relationship will positively advance patient-oriented research and clinical work.

Indexed as

EpilepsyMigraine DisordersMigraine with AuraAnticonvulsantsComorbidityHumansAnticonvulsantsAnti-seizure medicationEpilepsyGeneticsHemiplegic migraineMigraineMigralepsyNeurotransmitters

Identifiers

PMID38273253
PMCPMC10811828
OpenAlexW4391239467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.